Pay Attention to this Trade Activity as Korro Bio Inc (KRRO) last week performance was -2.87%

Shaun Noe

Korro Bio Inc (NASDAQ: KRRO) open the trading on Wednesday, with a bit cautious approach as it glided -4.21% to $31.42, before settling in for the price of $32.8 at the close. Taking a more long-term approach, KRRO posted a 52-week range of $10.29-$72.51.

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 21.83%. Meanwhile, its Annual Earning per share during the time was 21.83%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.06%. This publicly-traded company’s shares outstanding now amounts to $9.39 million, simultaneously with a float of $5.46 million. The organization now has a market capitalization sitting at $295.06 million. At the time of writing, stock’s 50-day Moving Average stood at $38.69, while the 200-day Moving Average is $23.54.

Korro Bio Inc (KRRO) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Korro Bio Inc’s current insider ownership accounts for 41.89%, in contrast to 63.97% institutional ownership.

Korro Bio Inc (KRRO) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.59 per share during the current fiscal year.

Korro Bio Inc’s EPS decrease for this current 12-month fiscal period is -6.06% and is forecasted to reach -9.26 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -3.13% through the next 5 years, which can be compared against the 21.83% growth it accomplished over the previous five years trading on the market.

Korro Bio Inc (NASDAQ: KRRO) Trading Performance Indicators

Let’s observe the current performance indicators for Korro Bio Inc (KRRO). It’s Quick Ratio in the last reported quarter now stands at 5.98. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 46.98.

In the same vein, KRRO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -9.75, a figure that is expected to reach -2.43 in the next quarter, and analysts are predicting that it will be -9.26 at the market close of one year from today.

Technical Analysis of Korro Bio Inc (KRRO)

[Korro Bio Inc, KRRO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 16.40% While, its Average True Range was 34.17.

Raw Stochastic average of Korro Bio Inc (KRRO) in the period of the previous 100 days is set at 44.50%, which indicates a major rise in contrast to 9.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.56 that was higher than 3.05 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.